Status:
UNKNOWN
Evaluation of C13 Breath Test for Upper Gastrointestinal Bleeding in Patients Who Need Double Antiplatelet After PCI
Lead Sponsor:
Chongqing Medical University
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
24-93 years
Brief Summary
Hp infection is closely related to upper gastrointestinal bleeding in patients who need dual-antiplatelet after PCI. Taking anti-Hp treatment has the effect of reducing bleeding risk. Thus, we propose...
Detailed Description
Our study is to retrospectively analyze the clinical data of 1606 patients of acute myocardial infarction who need dual- antiplatelet after PCI.The diagnostic criteria for upper gastrointestinal bleed...
Eligibility Criteria
Inclusion
- The diagnosis of patients with coronary heart disease is based on the diagnostic criteria of ACA/AHA,the diagnostic criteria for upper gastrointestinal bleeding refer to the guidelines for the diagnosis and treatment of acute non-variceal upper gastrointestinal bleeding.
- In the hospital, all patientsI were treated with clopidogrel 300 mg or ticagrelor 180 mg before surgery, and C13 breath test was performed after surgery.
- All patients were treated with dual- antiplatelet.
- The clinical data of the included subjects were complete.
Exclusion
- Patients with previous liver and kidney disease, Cr greater than 150 μmol / L, AST or ALT increased more than 2 times the normal value of patients.
- Patient with history of cerebrovascular disease.
- Patients with active gastrointestinal bleeding disease due to cirrhosis or other reasons before PCI.
- Patients with abnormal coagulation.
- Diabetic patients, diagnostic criteria for anemia: 8th edition of internal medicine, adult males with Hb less than 120g / L or RBC less than 4 × 10\^12 / L, adult women with Hb less than 105g / L or RBC than 3.5 × 10\^12 / L.
- Patients with incomplete medical records;7.Patient with pregnant.
- Patients with malignant tumors
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04012801
Start Date
January 1 2015
End Date
July 1 2020
Last Update
March 4 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.